| Obesity |
1 |
1 |
| Bariatric Surgery |
0 |
0.8 |
| Weight Loss |
0 |
1 |
| Weight Management |
0 |
1 |
| Surgery |
0 |
0.26 |
| Hospital |
0 |
0.17 |
| Massachusetts |
0 |
0.17 |
| Clinical Research |
0 |
0.13 |
| Dorsum |
0 |
0.13 |
| NHS |
0 |
0.13 |
| Patient Safety |
0 |
0.1 |
| GLP-1 Receptor Agonist |
0 |
0.07 |
| Type 2 Diabetes Mellitus |
0 |
0.8 |
| Health Care Reform |
0 |
0.06 |
| Adverse Effects |
0 |
0.04 |
| Behavioral Modification Therapy |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Constipation |
0 |
0.04 |
| Diarrhea |
0 |
0.04 |
| Diet |
0 |
0.8 |
| Emesis |
0 |
0.04 |
| Endocrinology |
0 |
0.8 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Lifestyle Counseling |
0 |
0.04 |
| Metabolism |
0 |
0.8 |
| Nausea |
0 |
0.04 |
| Nutrition |
0 |
0.8 |
| Outpatient Clinic |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Remission |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Stress |
0 |
0.04 |
| Texas |
0 |
0.04 |
| Tolerance |
0 |
0.04 |